Stay updated on LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.0%
    Check dated 2025-06-13T05:15:31.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.2.
    Difference
    0.8%
    Check dated 2025-06-06T01:01:51.000Z thumbnail image
  3. Check
    27 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-22T21:53:47.000Z thumbnail image
  4. Check
    49 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T05:54:28.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The webpage has undergone significant content changes, including the removal of detailed background information on mesothelioma treatments and the addition of a new study location and version revision. The focus has shifted to a specific study involving the drug LMB-100 and pembrolizumab.
    Difference
    56%
    Check dated 2025-04-16T14:48:26.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T09:57:46.000Z thumbnail image

Stay in the know with updates to LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.